Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
Authors
Keywords
-
Journal
Communications Biology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-28
DOI
10.1038/s42003-021-02136-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chromosome arm aneuploidies shape tumour evolution and drug response
- (2020) Ankit Shukla et al. Nature Communications
- Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma
- (2020) Alvaro Gonzalez-Rajal et al. Frontiers in Cell and Developmental Biology
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis
- (2019) Pia-Amata Leimbacher et al. MOLECULAR CELL
- The PSIPRED Protein Analysis Workbench: 20 years on
- (2019) Daniel W A Buchan et al. NUCLEIC ACIDS RESEARCH
- Casein kinase 2 regulates telomere protein complex formation through Rap1 phosphorylation
- (2019) Haruna Inoue et al. NUCLEIC ACIDS RESEARCH
- DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter
- (2019) Jiawei Yu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization
- (2019) Luna Kadouri et al. LUNG CANCER
- Cyclin A2 degradation during the spindle assembly checkpoint requires multiple binding modes to the APC/C
- (2019) Suyang Zhang et al. Nature Communications
- Old Soldiers Never Die: Is There Still a Role for Immunohistochemistry in the Era of Next-Generation Sequencing Panel Testing?
- (2019) Ming Sound Tsao et al. Journal of Thoracic Oncology
- CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer
- (2018) Wei Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
- (2018) Nam Nhut Phan et al. Oncotarget
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells
- (2018) Stephanie E. van Gijn et al. ONCOGENE
- Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma
- (2018) Kais Zakharia et al. Translational Oncology
- Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer
- (2017) Mark N. Adams et al. Journal of Thoracic Oncology
- MRE11 stability is regulated by CK2-dependent interaction with R2TP complex
- (2017) P von Morgen et al. ONCOGENE
- Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors
- (2017) Javier Pérez-Peña et al. Oncotarget
- Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer
- (2017) Pulari U. Thangavelu et al. Oncotarget
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Building a Regulatory Network with Short Linear Sequence Motifs: Lessons from the Degrons of the Anaphase-Promoting Complex
- (2016) Norman E. Davey et al. MOLECULAR CELL
- Multiomic Analysis of the UV-Induced DNA Damage Response
- (2016) Stefan Boeing et al. Cell Reports
- The ABBA Motif Binds APC/C Activators and Is Shared by APC/C Substrates and Regulators
- (2015) Barbara Di Fiore et al. DEVELOPMENTAL CELL
- Atomic structure of the APC/C and its mechanism of protein ubiquitination
- (2015) Leifu Chang et al. NATURE
- OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: A bioinformatic analysis combine with RNAi and oligonucleotide microarray
- (2015) QIPING HU et al. ONCOLOGY REPORTS
- A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
- (2015) G. Pilkington et al. THORAX
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Genome-wide transcriptome profiling of homologous recombination DNA repair
- (2014) Guang Peng et al. Nature Communications
- Ultradeep Human Phosphoproteome Reveals a Distinct Regulatory Nature of Tyr and Ser/Thr-Based Signaling
- (2014) Kirti Sharma et al. Cell Reports
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
- (2013) Romelia Salomon-Ferrer et al. Journal of Chemical Theory and Computation
- Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
- (2013) L R Martins et al. LEUKEMIA
- Insights into Degron Recognition by APC/C Coactivators from the Structure of an Acm1-Cdh1 Complex
- (2013) Jun He et al. MOLECULAR CELL
- Integrated proteomic analysis of post-translational modifications by serial enrichment
- (2013) Philipp Mertins et al. NATURE METHODS
- Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest
- (2012) Fumihiko Uchida et al. BMC CANCER
- CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy
- (2012) A. Siddiqui-Jain et al. MOLECULAR CANCER THERAPEUTICS
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage
- (2010) Xing Zeng et al. CANCER CELL
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
- (2010) A. Siddiqui-Jain et al. CANCER RESEARCH
- Structural basis of CX-4945 binding to human protein kinase CK2
- (2010) Andrew D. Ferguson et al. FEBS LETTERS
- Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
- (2010) Fabrice Pierre et al. JOURNAL OF MEDICINAL CHEMISTRY
- Improved side-chain torsion potentials for the Amber ff99SB protein force field
- (2010) Kresten Lindorff-Larsen et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started